Migraine trials recruiting in Florida

All Migraine trials nationally

Cities in Florida

Recruiting trials in Florida

• A Clinical Trial to Evaluate Efficacy and Safety of Xeomin® Injections for Preventing Chronic Migraine
  NCT07018713 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female) · Florida: Gulf Breeze, Homestead, Jacksonville, Lakeland
• A Clinical Trial to Evaluate Efficacy and Safety of Xeomin® Injections for Preventing Episodic Migraine
  NCT07018700 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female) · Florida: Gulf Breeze, Homestead, Jacksonville, Lakeland
• A Study With Eptinezumab in Adolescents (12-17 Years) With Chronic Migraine
  NCT04965675 · Phase: Phase 3 · Ages: 12 Years to 17 Years · Sex: All (male and female) · Florida: Gainesville, Gulf Breeze, Hialeah, Loxahatchee Groves
• A Study With Eptinezumab in Children and Adolescents (6 to 17 Years) With Chronic or Episodic Migraine
  NCT05164172 · Phase: Phase 3 · Ages: 6 Years to 17 Years · Sex: All (male and female) · Florida: Gulf Breeze, Hialeah, Loxahatchee Groves, Tampa
• A Study of Eptinezumab in Pediatric Participants With Episodic Migraine
  NCT05897320 · Phase: Phase 3 · Ages: 6 Years to 17 Years · Sex: All (male and female) · Florida: Gulf Breeze, Hialeah, Tampa
• A Study of Oral Atogepant Tablets to Assess Adverse Events and Change in Disease Activity To Prevent Migraine in Participants Aged 12 to 17 Years
  NCT06810505 · Phase: Phase 3 · Ages: 12 Years to 17 Years · Sex: All (male and female) · Florida: Gulf Breeze, Lakeland, Miami, Weston
• A Study to Assess the Adverse Events and Change in Disease Activity of Oral Atogepant Tablets in Pediatric Participants (6-17 Years of Age) With Episodic Migraine
  NCT05711394 · Phase: Phase 3 · Ages: 6 Years to 17 Years · Sex: All (male and female) · Florida: Gulf Breeze, Homestead, Miami, Spring Hill
• A Study to Evaluate IPN10200 Safety and Efficacy in the Prevention of Episodic or Chronic Migraine in Adults
  NCT06625060 · Phase: Phase 2 · Ages: 18 Years to 80 Years · Sex: All (male and female) · Florida: Boca Raton, Hialeah, Lake City, Ocala
• A Study to Investigate the Safety and Efficacy of MEDI0618 Compared to Placebo in Adult Participants With Episodic Migraine
  NCT06602479 · Phase: Phase 2 · Ages: 18 Years to 70 Years · Sex: All (male and female) · Florida: Homestead, Lake Mary, Miami, St. Petersburg
• A Study to Learn About the Safety of Taking an Additional Dose of the Medicine Rimegepant in Adults With Migraine
  NCT07609914 · Phase: Phase 4 · Ages: 18 Years and older · Sex: All (male and female) · Florida: Boca Raton, Miami, Orlando
• A Study to Learn About the Study Medicine Called Rimegepant in Women When Used for Intermittent Prevention of Menstrual Migraine
  NCT06641466 · Phase: Phase 3 · Ages: 18 Years to 45 Years · Sex: Female · Florida: Aventura, Hallandale, Jacksonville
• Comparative Effectiveness of Migraine Preventive Medications: The APT Comparison Study
  NCT06972056 · Phase: Phase 4 · Ages: 18 Years to 70 Years · Sex: All (male and female) · Florida: Hollywood, Jacksonville, Miami
• Efficacy and Safety Study of Rimegepant for the Preventative Treatment of Migraine in Pediatric Subjects
  NCT05156398 · Phase: Phase 3 · Ages: 6 Years to 17 Years · Sex: All (male and female) · Florida: Edgewater, Hialeah, Hollywood, Ormond Beach
• Long-term Safety Study of Rimegepant in Pediatric Subjects for the Acute Treatment of Migraine
  NCT04743141 · Phase: Phase 3 · Ages: 6 Years to 17 Years · Sex: All (male and female) · Florida: Miami, Orange Park, Orlando, Tampa
• Qudexy XR for the Prevention of Migraine in Children 6 to 11 Years Old
  NCT04748601 · Phase: Phase 4 · Ages: 6 Years to 11 Years · Sex: All (male and female) · Florida: Loxahatchee Groves, Orlando, Tampa
• Randomized Study in Children and Adolescents With Migraine: Acute Treatment
  NCT04649242 · Phase: Phase 3 · Ages: 6 Years to 17 Years · Sex: All (male and female) · Florida: Apopka, Cutler Bay, DeLand, Gainesville
• Real-world Prospective Study on the Use of Anti-CGRP Drugs in Migraine
  NCT07159750 · Phase: Not specified · Ages: 18 Years and older · Sex: All (male and female) · Florida: Miami
• Study Evaluating the Efficacy, Safety, and Tolerability of ASY202 (Dihydroergotamine Mesylate [DHE] Inhalation Powder Delivered Via a Multidose Dry Powder Inhaler) for the Acute Treatment of Migraine in Adult Patients
  NCT07646613 · Phase: Phase 2 · Ages: 18 Years to 65 Years · Sex: All (male and female) · Florida: Orlando
• Study of EVO756 in Adults With Migraine
  NCT07616128 · Phase: Phase 2 · Ages: 18 Years to 64 Years · Sex: All (male and female) · Florida: Jacksonville, Miami, Orlando, Tampa
• Study to Assess Adverse Events and Disease Activity of Oral Ubrogepant Tablets for the Acute Treatment of Migraine in Children and Adolescents (Ages 6-17)
  NCT05125302 · Phase: Phase 3 · Ages: 6 Years to 17 Years · Sex: All (male and female) · Florida: Boynton Beach, Fort Myers, Gainesville, Gulf Breeze